Michael Breslav

Title: Michael Breslav: Innovator in Pharmaceutical Chemistry

Introduction

Michael Breslav is a notable inventor based in Maple Glen, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for the treatment of epilepsy and inflammatory diseases.

Latest Patents

Breslav holds 2 patents, showcasing his innovative work. His latest patents include a sulfamide derivative useful for the treatment of epilepsy. This invention is directed to novel sulfamide derivatives, pharmaceutical compositions comprising said compounds, and methods for treating epilepsy and related disorders. The compounds can be administered alone or as co-therapy with one or more anticonvulsant and/or anti-epileptic agents. Another significant patent is for a process for preparing peptidyl heterocyclic ketone derivatives. This invention relates to novel processes for the preparation of peptidyl heterocyclic ketones, which are potent and selective inhibitors of tryptase. These compounds are useful for the treatment and prevention of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis.

Career Highlights

Throughout his career, Breslav has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Breslav has collaborated with notable professionals in his field, including Frank John Villani, Jr. and Brian D. Klein. These collaborations have further enhanced his research and development efforts.

Conclusion

Michael Breslav is a distinguished inventor whose work in pharmaceutical chemistry has led to important advancements in the treatment of epilepsy and inflammatory diseases. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.